| Field | Specification |
|---|---|
| Mfr No | |
| Assay Time | |
| Detection Method | |
| Product Type | |
| Sample Type(s) | Biological |
| Shipping | |
| Species | |
| Storage |
Overview
For quantitative determination of free and total sialic acid (NANA) and evaluation of drug effects on its metabolism. The assay uses OD570nm, or FL530/585nm for signal readout. Compatible sample input includes Biological. Typical stated assay timing is 2 hrs.
Key elements and design rationale
- Readout format: OD570nm, or FL530/585nm supports plate-based signal acquisition and consistent comparison across matched samples.
- Sample compatibility: The stated sample scope includes Biological, which is useful when aligning matrix type with calibration and control design.
- Analytical range context: The supplied specifications include a stated detection limit of OD, FL: 20, 2 µM for interpreting low-signal samples.
- Feature emphasis: Sensitive and accurate. Use as little as 10 µL samples. Linear detection range in 96-well plate: 0.02 to 1 mM sialic acid for colorimetric assays and 2 to 100 µM for fluorimetric assays.
Additional feature notes highlight Simple and convenient. Can detect free sialic acid by the addition of a single working reagent and incubation for 60 min at room temperature or total sialic acid by pre-treating samples with a 60 min hydrolysis step. Available format information for this listing includes 100 Tests.
Biological background
This product is centered on measurement of sialic acid within the matrices described for the assay. In practice, datasets from this type of format are typically interpreted by comparing relative signal, activity, or abundance across matched control and experimental groups rather than relying on a single value in isolation. Careful alignment of sample matrix, incubation window, and calibration strategy is important when comparing results across plates, operators, or study days.
More details
Sialic acid is a general name for nine-carbon acidic sugars with N- or O-substituted derivatives. The most common member of these sugars is N-acetylneuraminic acid (NANA). Sialic acid is widely distributed throughout mammalian tissues and fluids including serum. Sialylated oligosaccharides have been shown to exhibit antiviral properties and are also known to influence blood coagulation and cholesterol levels. The Sialic acid level in body fluids is also an important marker for diagnosing cancer. Simple, direct, and automation-ready procedures for measuring sialic acid concentrations find wide applications in research and drug discovery. BioAssay Systems’ sialic acid assay uses a single Working Reagent that combines NANA aldolase, pyruvate oxidase, and hydrogen peroxide determination in one step. The color intensity of the reaction product at 570nm or fluorescence intensity at λex/em = 530/585nm is directly proportional to the sialic acid concentration in the sample
Detection method
Colorimetric (OD 570 nm) or Fluorescent (FL 530/585 nm).
Detection limit and analytical sensitivity
Reported detection limit(s): Colorimetric: 20 µM / Fluorescent: 2 µM. Additional source wording: OD, FL: 20, 2 µM.
Procedures and timing
Stated procedure or timing information: 2 hrs.
Research relevance and current trends
- Plate-based quantification and side-by-side group comparison remain central use cases for this assay format.
- The description supports intervention-focused study designs in which researchers compare baseline and perturbed conditions.
- Short assay timing and plate compatibility support time-course or repeated-measure collection plans when handling is kept consistent.
Common research applications
- Quantify sialic acid in biological by OD570 nm, or FL530/585 nm readout.
- Compare treatment or phenotype groups using matched biological handling.
- Monitor time-course or pre/post changes in biological across study conditions.
Interpretation is usually strongest when signal changes are assessed alongside matrix-matched controls, replicate agreement, and the assay's stated analytical window.
Notes for experimental interpretation
- Matrix composition, background signal, and sample handling can influence apparent response; compare like-with-like whenever possible.
- Use appropriate blanks, controls, and replicate wells to distinguish biological differences from plate, reagent, or handling variability.
For laboratories requiring additional technical capacity, we provide scientific support services including assay execution, method guidance, product sourcing, and customization to align the assay with specific experimental objectives. If you need assistance selecting the appropriate kit configuration, adapting the workflow to your application, or identifying related research services, please click Talk to a Scientist, email support@biohippo.com, or review our Research Services; a member of our scientific team will follow up with recommendations tailored to your study.
Galactosialidosis: Preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept
Cadaoas, J., et al. (2021). Galactosialidosis: Preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept. Molecular Therapy – Methods & Clinical Development. 20: 191-203. Assay: Sialic acid in mouse urine.
Knockout of sialidase and pro-apoptotic genes in Chinese hamster ovary cells enables the production of recombinant human erythropoietin in fed-batch cultures
Ha, T. K., et al. (2020). Knockout of sialidase and pro-apoptotic genes in Chinese hamster ovary cells enables the production of recombinant human erythropoietin in fed-batch cultures. Metabolic Engineering. 57: 182-192. Assay: Sialic acid in hamster cell line recombinant erythropoietin.
Conventional and unconventional therapeutic strategies for sialidosis type I
Mosca, R., et al. (2020). Conventional and unconventional therapeutic strategies for sialidosis type I. Journal of Clinical Medicine. 9(3): 695. Assay: Sialic acid in mouse urine.
An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics
Odaka, H., et al. (2021). An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics. Neurobiology of Disease. 152: 105279. Assay: Sialic acid in human fibroblast.
Serum Sialic Acids Levels According to the Severity of Liver Cirrhosis
Chrostek, L et al (2014). Serum Sialic Acids Levels According to the Severity of Liver Cirrhosis. Journal of clinical laboratory analysis. Assay: Sialic acid in human serum.
Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases
Chrostek, L et al (2014). Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases. Rheumatol International. 34(3):393-9. Assay: Sialic acid in human serum.
Partial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification
Ganther, M et al (2014). Partial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification. J Lipid Res. 55(12):2692-704. Assay: Sialic acid in bovine brain gangliosides.
Effect of lithium chloride on the production and sialylationof Fc-fusion protein in Chinese hamster ovary cell culture
Ha, TK, Kim, YG, Lee, GM (2014). Effect of lithium chloride on the production and sialylationof Fc-fusion protein in Chinese hamster ovary cell culture. Appl Microbiol Biotechnol. 98(22):9239-48. Assay: Sialic acid in hamster ovary cells.
Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis
Bonten, EJ et al (2013). Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832.10: 1784-1792. Assay: Sialic acid in mouse kidney tissue.
Structural and biochemical characterization of the broad substrate specificity of Bacteroides thetaiotaomicron commensal sialidase
Park, KH et al (2013). Structural and biochemical characterization of the broad substrate specificity of Bacteroides thetaiotaomicron commensal sialidase. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics1834.8: 1510-1519. Assay: Sialic acid in B. thetaiotaomicron cells.
Methods for treatment of a sarcoma using an epimetabolic shifter (CoEnzyme Q10)
Sarangarajan, R et al(2011). Methods for treatment of a sarcoma using an epimetabolic shifter (CoEnzyme Q10). US Patent Appl. US 2011/0064747 A1. Assay: Sialic Acid in lipoproteins.
The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics
Cylwik B et al (2010). The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics. Alcohol Alcohol. 45(5):422-6. Assay: Sialic acid in human serum.
The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics
Cylwik B, et al (2010). The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics. Alcohol Alcohol. 45(5):422-6. Assay: Sialic acid in lipoproteins.